L&K Biomed "Strengthening Crisis Response Capability in COVID-19 Situation through Business Normalization"

[Asia Economy Reporter Hyungsoo Park] Kang Guk-jin and Park Geun-joo, co-CEOs of L&K Biomed, stated at the New Year's ceremony on the 3rd, "This year will be a pivotal year for L&K Biomed to become a successful company." They added, "We will strengthen our ability to respond to the COVID-19 crisis through business normalization."

Co-CEOs Kang Guk-jin and Park Geun-joo said, "We intend to make this year the first year of business normalization to overcome the current crisis and write a new history," and presented specific work directions such as improving the management system.

They continued, "To overcome the crisis, we will accelerate the discovery of new clients through aggressive marketing to increase sales," emphasizing, "We must deeply recognize that maximizing operating profit is the only way for a company to survive."

Additionally, they stressed, "A roadmap to overcome the crisis must be established in all sectors, and a cost reduction system must be built," adding, "Through securing business continuity, we must realize shareholder value for shareholders and investors who have suffered from the recent stock price decline."

The co-CEOs stated, "A successful company is not one that grows quickly, but a long-lasting company that has proven its ability to quickly respond to environmental changes and manage the associated risks," and said, "Let us take this crisis not as a failure or setback but as an opportunity to leap into a successful company by improving our management structure and pioneering new paths."

This content was produced with the assistance of AI translation services.